Sign inSubmit
ArticleMetrics
Research Article · Free to read · Published 30 June 2010

The Development of a Revised Canadian Myalgic Encephalomyelitis Chronic Fatigue Syndrome Case Definition

Leonard A. Jason1, Meredyth Evans1, Nicole Porter1, Molly Brown1, Abigail Brown1, Jessica Hunnell1, Valerie Anderson1, Athena Lerch1, Kenny De Meirleir2 & Fred Friedberg3

American Journal of Biochemistry and Biotechnology, Volume 6, Issue 2, pp. 120–135 · doi.org/10.3844/ajbbsp.2010.120.135

33,208 accesses12,913 downloads147 citations (Crossref)Metrics
Cite Check for updates

Abstract

Problem statement: Several investigators have indicated that case definitions for Chronic Fatigue Syndrome (CFS) are characterized by vaguely worded criteria that lack operational definitions and guidelines. The most widely used CFS case definition is the Fukuda et al. criteria, which uses polythetic criteria (i.e., patients are only required to have four out of a possible eight symptoms). Yet two of these eight symptoms (post-exertional malaise and memory/concentration problems) are an essential feature of this illness and the Fukuda et al. criteria do not require that these symptoms be present among all patients. Significant methodological problems could occur if investigators in different settings recruit samples with different percentages of these core symptoms. In contrast, the Canadian clinical case definition does require specific ME/CFS symptoms such as post-exertional malaise and memory/concentration problems. The provision of operationally explicit, objective criteria on specific key symptoms might reduce criterion variance as a source of unreliability. In addition, the use of structured interview schedules will ensure that symptoms are assessed in a consistent way across settings. Conclusion/Recommendations: In this article, we specified explicit rules for determining whether critical symptoms meet ME/CFS criteria using a revised Canadian case definition and a questionnaire has been developed to assess core symptoms. It is hoped that these developments will lead to increased reliability of this revised Canadian case definition as well as more frequent use of these criteria by investigators.

Licence and reuse

Free to read. This article carries the publisher’s copyright, as printed on it: © 2010 Science Publications. It is free to read; ask us before reusing it.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Jason, L. A., Evans, M., Porter, N., Brown, M., Brown, A., Hunnell, J., Anderson, V., Lerch, A., De Meirleir, K. & Friedberg, F. (2010). The Development of a Revised Canadian Myalgic Encephalomyelitis Chronic Fatigue Syndrome Case Definition. American Journal of Biochemistry and Biotechnology, 6(2), 120–135. https://doi.org/10.3844/ajbbsp.2010.120.135

Licence
© Science Publications
Issue
Volume 6, Issue 2
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
The Development of a Revised Canadian Myalgic Encephalomyelitis Chronic Fatigue Syndrome Case DefinitionAmerican Journal of Biochemistry and Biotechnology · Volume 6, Issue 2 · pp. 120–135 · © Science PublicationsDownload